1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
NCI SBIR/STTR Training and Entrepreneurship Program (STEP) is sponsored by National Cancer Institute (NCI). The NCI SBIR/STTR Training and Entrepreneurship Program (STEP) assists small businesses in applying for Phase I Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding. The program offers structured training and customized assistance in entrepreneurship and application development.
Digital Health Tools and Software Platforms for Cancer-Related Technologies are among the NCI SBIR/STTR research topics.
Get alerted about grants like this
Save a search for “National Cancer Institute (NCI)” or related topics and get emailed when new opportunities appear.
Search similar grants →Based on current listing details, eligibility includes: Small businesses established in the US that have not received an NIH SBIR/STTR award in the last 10 years. Applicants must be for-profit US small businesses with 500 or fewer employees, including affiliates, and work must be performed in the US. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Not specified (provides training and support for Phase I SBIR/STTR funding) Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is May 15, 2026. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed) is sponsored by National Cancer Institute (NCI). This NOFO encourages applications promoting transformative discoveries in cancer biology and/or oncology through the use of nanotechnology. It specifically mentions the integration of modeling and simulation approaches to guide rational nanomaterial design and the use of artificial intelligence (AI) and modeling to aid rational drug design. This directly relates to personalized medicine and cancer treatment, though the primary focus is nanotechnology.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
NIH NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is a grant from the National Institutes of Health (NIH) / National Cancer Institute (NCI) that funds early-stage postdoctoral researchers in cancer-related fields to transition to independent research careers. The award provides a mentored phase (K99) followed by an independent phase (R00), supporting investigators who do not require an extended period of supervised training beyond their doctoral degrees. Eligible applicants must hold a research or clinical doctoral degree and be postdoctoral fellows who have not yet established independent research careers. The March 11, 2026 due date applies; award amounts vary by project.